Results 111 to 120 of about 33,513 (195)

A Multicenter, Open‐Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST)

open access: yes
American Journal of Hematology, Volume 101, Issue 10, Page 2666-2671, October 2026.
Kenneth I. Ataga   +8 more
wiley   +1 more source

Severe Hypokalemia With Rhabdomyolysis—A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Magnesium administration should be considered in severe or refractory hypokalemia with even normal serum magnesium; however, more research is needed to establish the evidence and take into account confounding factors. Severe hypokalemia can manifest with rhabdomyolysis, which can affect kidney function.
Tahir Shahzad, Alexandra Murray
wiley   +1 more source

Primary Hyperaldosteronism as a Cause of Resistant Hypertension: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT In young patients with resistant hypertension and hypokalemia, primary hyperaldosteronism should be suspected. Biochemical assessment and adrenal imaging could identify surgically curable aldosterone‐producing adenomas, and a normalization of blood pressure, potassium levels, and symptom resolution can be achieved through adrenalectomy.
Wasif Majeed Chaudhry   +3 more
wiley   +1 more source

Angiotensin receptor blocker losartan inhibits tumor growth of colorectal cancer

open access: yes, 2021
The renin-angiotensin system (RAS) is up-regulated in patients with colorectal cancer (CRC) and is reported to be associated with poor prognosis and chemo-resistance.
Reyhaneh Moradi-Marjaneh (16266725)   +13 more
core  

THE COMPARISON OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR ANTAGONISTS IN PATIENTS WITH MODERATE CHRONIC RENAL FAILURE

open access: yesTurkish Journal of Nephrology, 2019
In this prospective-randomised study, the effects of angiotensin converting enzyme inhibitors (enaiapril) and angiotensin receptor antagonists (losartan) use on various laboratory parameters in 27 patients with moderate chronic renal failure were ...
Alaattin YILDIZ   +7 more
doaj  

Efficacy of Telmisartan in MASLD/NAFLD: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Evidence from six randomized controlled trials indicates that telmisartan offers modest glycemic benefit but does not consistently improve metabolic, biochemical, or histological outcomes in MASLD/NAFLD, highlighting the need for larger, well‐designed clinical trials.
Shayan Shojaei   +12 more
wiley   +1 more source

Losartan alleviated synovitis in patients with metabolic osteoarthritis by down-regulating AT1R to inhibit TGF-β signaling

open access: yesJournal of Orthopaedic Surgery and Research
Previous studies have shown that losartan can alleviate the progression of osteoarthritis (OA). This study aimed to further explore the therapeutic effect and mechanism of losartan on metabolic OA.
Haonan Zhang   +6 more
doaj   +1 more source

Eating Behavior, Food Consumption Frequency, and Nutritional Status Among Undergraduate Nursing Students: A Cross‐Sectional Study

open access: yesFood Science &Nutrition, Volume 14, Issue 9, September 2026.
In a cross‐sectional study of 61 undergraduate nursing students in Brazil, dietary patterns were centered on rice, beans, and bread, with limited fruit and vegetable diversity and frequent coffee consumption (72.1% daily or weekly). Despite a predominantly eutrophic BMI profile (65.0%), eating behavior (TFEQ‐21 domains: Cognitive Restraint ...
Maria Laura Lacerda Nascimento   +4 more
wiley   +1 more source

Losartan-induced acute interstitial nephritis [PDF]

open access: yes, 2007
Nefrite intersticial aguda é uma causa comum de perda aguda de função renal. Exposição a drogas é o fator desencadeante mais freqüentemente relatado, porém auto-imunidade e infecções também estão associadas.
Miltersteiner, Diego da Rosa   +7 more
core  

Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant‐Based Therapies: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, encompassing coronary artery disease, hypertension, heart failure, and cerebrovascular disorders. The global burden of CVD continues to rise, driven by complex interactions among endothelial dysfunction, oxidative stress, inflammation,
Nawfal Hasan Siam   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy